Unlocking the Potential of C1orf87: A Promising Drug Target and Biomarker

Target Name: C1orf87

NCBI ID: G127795

C1orf87

Unlocking the Potential of C1orf87: A Promising Drug Target and Biomarker

Introduction

C1orf87, also known as chromosome 1 open reading frame 87, is a gene located on chromosome 1 that has been gaining attention due to its potential involvement in various diseases. C1orf87 is a non-coding RNA molecule that has been shown to play a critical role in the regulation of cellular processes, including cell adhesion, migration, and survival. In recent years, researchers have made significant discoveries about the functions of C1orf87, and this has piqued the interest of researchers as a drug target and biomarker.

Diseases and Their link to C1orf87

Several diseases have been associated with the abnormal expression or dysfunction of C1orf87. One of the most well-known is cancer. Studies have shown that C1orf87 is highly expressed in various types of cancer, including breast, ovarian, and prostate cancers. This increased expression is thought to contribute to the development and progression of these diseases.

In addition to cancer, C1orf87 has also been linked to a number of other diseases, including neurodegenerative disorders, autoimmune diseases, and developmental disorders. For example, research has shown that individuals with certain forms of neurodegenerative disorder, such as Alzheimer's disease, have increased levels of C1orf87 in their brain.

C1orf87 as a Drug Target

C1orf87 has the potential to serve as a drug target due to its unique structure and its involvement in various cellular processes. One of the main reasons for its potential as a drug target is its structural complexity. C1orf87 is a long non-coding RNA molecule that contains multiple domains, including a T-box domain, a Z-repeat region, and a tail region. These domains give C1orf87 a unique structure that makes it difficult to target with small molecules.

However, researchers have been able to identify small molecules that can interact with C1orf87 and modulate its activity. These small molecules include inhibitors of the T-box domain, such as INCB01220 and MK-8628, as well as small molecules that can bind to the Z -Duplicate region, such as Fly system inhibitors like KO-332 and IDH88.

Another reason why C1orf87 may be a drug target is its involvement in cellular processes that are important for human health. For example, C1orf87 has been shown to play a role in cell adhesion and migration, which are important for the development and progression of cancer. Additionally, C1orf87 has been linked to the regulation of cellular processes that are important for brain development and function.

C1orf87 as a Biomarker

C1orf87 may also have the potential to serve as a biomarker for a number of diseases. Its increased expression in various diseases, as well as its unique structure and the small molecules that have been shown to interact with it, make it a promising candidate for use as a biomarker.

One of the main applications of C1orf87 as a biomarker is its potential to serve as a diagnostic marker for cancer. Studies have shown that C1orf87 is highly expressed in various types of cancer, including breast, ovarian, and prostate cancers. This increased expression makes C1orf87 a potentially useful diagnostic marker for these diseases.

In addition to cancer, C1orf87 has also been linked to a number of other diseases, including neurodegenerative disorders, autoimmune diseases, and developmental disorders. For example, research has shown that individuals with certain forms of

Protein Name: Chromosome 1 Open Reading Frame 87

The "C1orf87 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about C1orf87 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets